Sign in to view content

Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use

Blake A. Cooper, MD MPH

Video
Published 2022

Related

A Randomized Trial of Intravitreous Anti-VEGF for Prevention of Vision Threatening Complications of Diabetic Retinopathy (Protocol W)
Raj K. Maturi, MD
Updates from the Field
2021
High-Dose Anti-VEGF: Cross-Trial Analysis of Different Doses and Antagonists for the Treatment of Diabetic Macular Edema
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
On Demand Cases, Courses, and Papers
2019
Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2017

Category: Diabetic Retinopathy

Diabetic Retinopathy

See more